ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/21 | 1,646 | 1,739 | 1,622 | 1,719 | +50 | +3% | 283,400 |
2019/05/20 | 1,680 | 1,680 | 1,640 | 1,669 | +4 | +0.2% | 94,800 |
2019/05/17 | 1,699 | 1,707 | 1,650 | 1,665 | +6 | +0.4% | 121,200 |
2019/05/16 | 1,681 | 1,688 | 1,636 | 1,659 | +47 | +2.9% | 182,400 |
2019/05/15 | 1,664 | 1,669 | 1,587 | 1,612 | -36 | -2.2% | 254,600 |
2019/05/14 | 1,650 | 1,665 | 1,632 | 1,648 | -33 | -2% | 219,700 |
2019/05/13 | 1,711 | 1,720 | 1,666 | 1,681 | -35 | -2% | 110,700 |
2019/05/10 | 1,759 | 1,785 | 1,700 | 1,716 | -28 | -1.6% | 192,900 |
2019/05/09 | 1,785 | 1,799 | 1,738 | 1,744 | -36 | -2% | 109,800 |
2019/05/08 | 1,822 | 1,843 | 1,769 | 1,780 | -96 | -5.1% | 227,600 |
2019/05/07 | 1,834 | 1,892 | 1,763 | 1,876 | +14 | +0.8% | 269,900 |
2019/04/26 | 1,901 | 1,904 | 1,812 | 1,862 | -70 | -3.6% | 285,100 |
2019/04/25 | 1,937 | 1,961 | 1,901 | 1,932 | -9 | -0.5% | 270,100 |
2019/04/24 | 2,000 | 2,005 | 1,936 | 1,941 | -54 | -2.7% | 151,400 |
2019/04/23 | 2,018 | 2,040 | 1,932 | 1,995 | -8 | -0.4% | 297,200 |
2019/04/22 | 1,900 | 2,045 | 1,864 | 2,003 | +73 | +3.8% | 545,700 |
2019/04/19 | 2,020 | 2,023 | 1,888 | 1,930 | ±0 | ±0% | 547,700 |
2019/04/18 | 1,845 | 2,114 | 1,827 | 1,930 | +108 | +5.9% | 1,728,900 |
2019/04/17 | 1,782 | 1,845 | 1,776 | 1,822 | +46 | +2.6% | 225,500 |
2019/04/16 | 1,801 | 1,831 | 1,772 | 1,776 | -44 | -2.4% | 175,200 |
2019/04/15 | 1,829 | 1,864 | 1,804 | 1,820 | +10 | +0.6% | 276,700 |
2019/04/12 | 1,800 | 1,849 | 1,783 | 1,810 | +15 | +0.8% | 274,800 |
2019/04/11 | 1,768 | 1,815 | 1,756 | 1,795 | +5 | +0.3% | 252,700 |
2019/04/10 | 1,741 | 1,831 | 1,726 | 1,790 | +59 | +3.4% | 371,700 |
2019/04/09 | 1,783 | 1,789 | 1,662 | 1,731 | +68 | +4.1% | 215,300 |
2019/04/08 | 1,631 | 1,671 | 1,626 | 1,663 | +34 | +2.1% | 135,400 |
2019/04/05 | 1,620 | 1,636 | 1,605 | 1,629 | +3 | +0.2% | 83,000 |
2019/04/04 | 1,648 | 1,654 | 1,618 | 1,626 | -35 | -2.1% | 122,600 |
2019/04/03 | 1,658 | 1,679 | 1,637 | 1,661 | -13 | -0.8% | 96,200 |
2019/04/02 | 1,728 | 1,737 | 1,656 | 1,674 | -54 | -3.1% | 129,500 |
2019/04/01 | 1,750 | 1,751 | 1,712 | 1,728 | +8 | +0.5% | 85,800 |
2019/03/29 | 1,780 | 1,787 | 1,715 | 1,720 | -52 | -2.9% | 109,100 |
2019/03/28 | 1,705 | 1,786 | 1,653 | 1,772 | +34 | +2% | 207,300 |
2019/03/27 | 1,710 | 1,752 | 1,688 | 1,738 | +40 | +2.4% | 130,700 |
2019/03/26 | 1,640 | 1,698 | 1,630 | 1,698 | +70 | +4.3% | 172,600 |
2019/03/25 | 1,650 | 1,652 | 1,622 | 1,628 | -48 | -2.9% | 147,100 |
2019/03/22 | 1,703 | 1,706 | 1,664 | 1,676 | -32 | -1.9% | 154,300 |
2019/03/20 | 1,731 | 1,758 | 1,700 | 1,708 | -12 | -0.7% | 168,400 |
2019/03/19 | 1,759 | 1,774 | 1,720 | 1,720 | -66 | -3.7% | 196,700 |
2019/03/18 | 1,806 | 1,815 | 1,754 | 1,786 | -9 | -0.5% | 80,000 |
2019/03/15 | 1,875 | 1,875 | 1,793 | 1,795 | -44 | -2.4% | 94,600 |
2019/03/14 | 1,825 | 1,878 | 1,782 | 1,839 | +42 | +2.3% | 144,700 |
2019/03/13 | 1,803 | 1,835 | 1,783 | 1,797 | -6 | -0.3% | 56,600 |
2019/03/12 | 1,790 | 1,826 | 1,781 | 1,803 | +28 | +1.6% | 57,000 |
2019/03/11 | 1,802 | 1,827 | 1,756 | 1,775 | -27 | -1.5% | 68,400 |
2019/03/08 | 1,851 | 1,880 | 1,802 | 1,802 | -84 | -4.5% | 107,500 |
2019/03/07 | 1,901 | 1,901 | 1,841 | 1,886 | -25 | -1.3% | 92,800 |
2019/03/06 | 1,959 | 1,960 | 1,876 | 1,911 | -15 | -0.8% | 152,300 |
2019/03/05 | 1,893 | 1,947 | 1,882 | 1,926 | +9 | +0.5% | 92,700 |
2019/03/04 | 1,920 | 1,950 | 1,904 | 1,917 | -1 | -0.1% | 102,100 |
1501~
1550
件表示中 / 2460件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 45,900円 | +150.0% | - | 0.00% | - | 23.29倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 51,800円 | +14.3% | - | 3.86% | 21.04倍 | 1.34倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
タウンズ | 52,300円 | +4.6% | +6.1% | 5.35% | 8.92倍 | 3.30倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
クオリプス | 588,000円 | +237.1% | - | 0.00% | - | 8.63倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
生化学 | 62,500円 | -9.6% | -30.2% | 4.80% | 25.26倍 | 0.47倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム